Counteractive effects of a partial (sabcomeline) and a full (RS86) muscarinic receptor agonist on deficits in radial maze performance induced by S-AMPA lesions of the basal forebrain and medial septal area.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Behavioural Brain Research

• Publication date

  1999-02-15

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/S0166-4328(98)00075-8PMID 10512575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory

  2005cited by this paper
• Cholinergic modulation of memory in rats

  2004cited by this paper
• Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects

  2004cited by this paper
• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

  2004cited by this paper
• The separate and combined effects of scopolamine and nicotine on human information processing

  2004cited by this paper
• Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

  2004cited by this paper
• Sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, reverses delay-induced deficits in the T-maze

  1998cited by this paper
• SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.

  1997cited by this paper
• 647 Efficacy and safety of SB 202026 as a symptomatic treatment for Alzheimer's disease

  1996cited by this paper
• Intact spatial learning following lesions of basal forebrain cholinergic neurons.

  1996cited by this paper
• Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system

  1996cited by this paper
• Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: role of the septohippocampal projection.

  1995cited by this paper
• Astrocyte transplants alleviate lesion induced memory deficits independently of cholinergic recovery.

  1995cited by this paper
• Effects of Nicotine on Biological Systems II

  1995cited by this paper
• AF150(S): a new functionally selective M1 agonist improves cognitive performance in rats.

  1995cited by this paper
• Preclinical and phase 1 clinical characterization of CI-979/RU35926, a novel muscarinic agonist for the treatment of Alzheimer's disease.

  1995cited by this paper
• Acetylcholine: a neurotransmitter for learning and memory?

  1995cited by this paper
• The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system

  1995cited by this paper
• 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells.

  1995cited by this paper
• Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system.

  1994cited by this paper
• Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

  1994cited by this paper
• Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis

  1994cited by this paper
• Distinct kinetic binding propeties of N‐[3H]‐methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain

  1993cited by this paper
• The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory.

  1993cited by this paper
• WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.

  1993cited by this paper
• Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

  1993cited by this paper
• Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain.

  1993cited by this paper
• Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia.

  1993cited by this paper
• Chapter 49: Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia

  1993cited by this paper
• Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime.

  1992cited by this paper
• L‐689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors

  1992cited by this paper
• Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

  1991cited by this paper
• Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery.

  1991cited by this paper
• A critical evaluation of monkey models of amnesia and dementia.

  1991cited by this paper
• The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions.

  1991cited by this paper
• Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• The role of the Forebrain Cholinergic Projection System in Performance in the Radial-Arm Maze in Memory-Impaired Rats

  1991cited by this paper
• Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats.

  1990cited by this paper
• Effects of nicotine, oxotremorine and 9-amino 1,2,3,4- tetrahydroacridine (tacrine) on matching and non matching to position in rats: no evidence for mnemonic enhancement

  1990cited by this paper
• Cognitive models and cholinergic drugs.

  1989cited by this paper
• Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system.

  1989cited by this paper
• The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type

  1989cited by this paper
• Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.

  1989cited by this paper
• Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes.

  1989cited by this paper
• Effects of cholinergic drugs on learning impairment in ventral globus pallidus-lesioned rats.

  1989cited by this paper
• Comparative effects of quisqualic and ibotenic acid-induced lesions of the substantia innominata and globus pallidus on the acquisition of a conditional visual discrimination: differential effects on cholinergic mechanisms.

  1989cited by this paper
• The Cholinergic Hypothesis of Memory: A Review of Animal Experiments

  1988cited by this paper
• Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.

  1988cited by this paper
• Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's Disease

  1988cited by this paper
• Cholinergic side-effects of tetrahydroaminoacridine.

  1988cited by this paper
• Nicotine impairs acquisition of radial maze performance in rats.

  1988cited by this paper
• Handbook of Psychopharmacology

  1988cited by this paper
• Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects

  1988cited by this paper
• Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.

  1988cited by this paper
• The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination: implications for cholinergic hypotheses of learning and memory.

  1987cited by this paper
• Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs.

  1986cited by this paper
• The Cholinergic Neurotransmitter System in Human Memory and Dementia: A Review

  1986cited by this paper
• Medial septal and nucleus basalis magnocellularis lesions produce order memory deficits in rats which mimic symptomatology of Alzheimer's disease.

  1986cited by this paper
• Treatment development strategies for Alzheimer's disease

  1986cited by this paper
• Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.

  1985cited by this paper
• Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

  1985cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• A rapid radiochemical method for the determination of choline acetyltransferase

  1975cited by this paper
• Muscarinic cholinergic binding in rat brain.

  1974cited by this paper
• Attenuation of stimulus sensitivity by scopolamine

  1971cited by this paper

• Muscarinic receptor pharmacology and circuitry for the modulation of cognition.

  2012cites this paper
• Cholinergics/Anticholinergics/Muscarinics/Nicotinics

  2010cites this paper
• Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.

  2010cites this paper
• Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice

  2010cites this paper
• Cognitive Effects of Second-Generation Antipsychotics

  2009cites this paper
• M1 Muscarinic Acetylcholine Receptor Agonism Alters Sleep without Affecting Memory Consolidation

  2006cites this paper
• Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits.

  2004cites this paper
• Effect of sabcomeline on muscarinic and dopamine receptor binding in intact mouse brain

  2003cites this paper
• Excitotoxic lesioning of the rat basal forebrain with S-AMPA: consequent mineralization and associated glial response.

  2003cites this paper
• THE ROLE OF THE SEPTOHIPPOCAMPAL CHOLINERGIC SYSTEM IN COGNITIVE FUNCTIONS

  2001cites this paper